# A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001

> **NCT01403155** · PHASE1 · COMPLETED · sponsor: **Inovio Pharmaceuticals** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** INO-3401 + EP

## Key facts

- **NCT ID:** NCT01403155
- **Lead sponsor:** Inovio Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01403155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01403155, "A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01403155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*